The North America insulin pen market is expected to reach US$ 3,907.9 Mn in 2027 from US$ 1,880.7 Mn in 2018.
The market is estimated to grow with a CAGR of 8.7% from 2019-2027. The growth of the market is driven by the factors such as, growing geriatric population and rising incidence of diabetes. However, the market is likely to get impacted due to availability of alternatives for drug delivery and limitations associated with insulin pens in the region.
Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes namely diabetes type-I also known as diabetes insipid us and diabetes type-II also termed as diabetes mellitus. Incidences and prevalence of diabetes is steadily increasing across the globe. In high-income countries up to 91% of adults with the disease have type 2 diabetes.
According to International Diabetes Federation (IDF), approximately 425 million people were living with diabetes in 2017and it is expected to reach 629 million by 2045 across the globe. In 2015, around 9.4% of the population of the U.S. had diabetes, including 30.2 million adults aged 18 years and over. .Additionally, according to Centers for Disease Control and Prevention's report that 4% of people aged 18 to 44 years are living with diabetes, 17 percent of those aged 45 to 64 years, and 25.2 percent of those aged over 65 years are living with diabetes. The following table represents number of patients suffering with diabetes across various North American countries worldwide.
US is expected to lead the market in the North America region owing to rise in the prevalence of the diabetes and growing elder population in the region. However, the country lags behind the other developed countries that can be a restrain to the market growth. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.
NORTH AMERICA DIABETES CARE DEVICES – MARKET SEGMENTATION
By Product
By End User
By Distribution Channel
By Geography
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 1,880.7 Million |
| Market Size by 2027 | US$ 3,907.9 Million |
| CAGR (2019 - 2027) | 8.7% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Insulin Pens Market is valued at US$ 1,880.7 Million in 2018, it is projected to reach US$ 3,907.9 Million by 2027.
As per our report North America Insulin Pens Market, the market size is valued at US$ 1,880.7 Million in 2018, projecting it to reach US$ 3,907.9 Million by 2027. This translates to a CAGR of approximately 8.7% during the forecast period.
The North America Insulin Pens Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Insulin Pens Market report:
The North America Insulin Pens Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Insulin Pens Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Insulin Pens Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Insulin Pens Market
